The Beauty Health Company (NASDAQ:SKIN) Stock Short Interest Report for October

The Beauty Health Company (NASDAQ:SKIN) saw a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 375,655 shares, a decline of 94.8% from the September 30th total of 7,247,126 shares. Based on an average daily trading volume, of 26,346 shares, the days-to-cover ratio is currently 14.3 days. Currently, 9.0% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Beauty Health in a research note on Wednesday, October 21st. Jefferies Financial Group restated a “hold” rating and issued a $11.00 target price (up from $0.85) on shares of Beauty Health in a report on Monday, October 19th. TD Cowen dropped their target price on Beauty Health from $20.00 to $18.00 and set a “hold” rating on the stock in a report on Wednesday, August 12th. Canaccord Genuity Group set a $11.00 target price on Beauty Health and gave the stock a “hold” rating in a report on Thursday, October 22nd. Finally, Zacks Research cut shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $18.00.

Institutional Investors Weigh In On Beauty Health

Several institutional investors have recently bought and sold shares of SKIN. Bank of America Corp DE raised its holdings in Beauty Health by 19.2% during the first quarter. Bank of America Corp DE now owns 106,242 shares of the company’s stock worth $95,000 after acquiring an additional 17,088 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of Beauty Health by 29.6% during the 1st quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock worth $253,000 after purchasing an additional 64,900 shares during the last quarter. Capricorn Fund Managers Ltd bought a new stake in shares of Beauty Health in the 1st quarter valued at about $17,270,000. Finally, Diversified Trust Co bought a new stake in shares of Beauty Health in the 1st quarter valued at about $25,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Price Performance

SKIN traded down $0.34 during midday trading on Tuesday, hitting $10.18. The company had a trading volume of 18,777 shares, compared to its average volume of 62,385. Beauty Health has a twelve month low of $9.89 and a twelve month high of $34.80. The firm’s 50-day simple moving average is $12.64 and its 200-day simple moving average is $17.24. The company has a market capitalization of $66.24 million, a PE ratio of -2.31 and a beta of 1.05. The company has a debt-to-equity ratio of 4.36, a quick ratio of 1.48 and a current ratio of 1.76.

Beauty Health (NASDAQ:SKIN) last issued its earnings results on Thursday, August 6th. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.50) by $0.10. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The company had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Equities research analysts predict that Beauty Health will post -3.18 EPS for the current fiscal year.

About Beauty Health

BeautyHealth is a global health and beauty company focused on providing technology, products and services for aesthetic and skincare businesses. Its flagship brand, HydraFacial, offers a non-invasive treatment platform that combines cleansing, exfoliation, extraction and hydration, with treatments delivered through proprietary devices and consumable solutions.

The company also provides professional skincare products, treatment systems and related solutions designed for use by physicians, dermatologists, aestheticians and other licensed practitioners.